Cynthia Larive

**Title: Innovations by Inventor Cynthia Larive in Lawrence, KS**

Introduction

Cynthia Larive, an innovative inventor based in Lawrence, Kansas, has made significant strides in the field of antibiotic research. With her unique approach to harnessing natural compounds, she has developed an important tool for treating bacterial infections.

Latest Patents

Larive holds a patent for Methanobactin, a copper-binding compound with notable antibiotic and antioxidant properties. This innovative compound, isolated from methanotrophic bacteria, presents a means and method for effectively addressing bacterial infections. Methanobactin is particularly remarkable as it represents the first antibiotic of its class with gram-positive activity. Its structural formula has been sequenced, showcasing the detailed scientific work behind its development.

Career Highlights

Cynthia Larive has spent her career contributing to academic and research institutions, including the University of Kansas and the Iowa State University Research Foundation, Inc. Her dedication to understanding and utilizing bacterial compounds has paved the way for advancements in antibiotic treatment.

Collaborations

Throughout her career, Larive has collaborated with esteemed colleagues, including Alan A. DiSpirito and James A. Zahn. These partnerships have played a vital role in advancing her research and the development of new medical solutions.

Conclusion

Cynthia Larive's work exemplifies the impact of innovative thinking in the realm of antibiotic development. Her patent for Methanobactin not only highlights her contributions to science but also provides a promising avenue for tackling bacterial infections. As she continues her research, the implications of her findings will likely influence the future of antibiotic treatments.